128 related articles for article (PubMed ID: 1465969)
21. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
[TBL] [Abstract][Full Text] [Related]
22. FK 506: an effective immunosuppressant for islet xenotransplantation.
Tze WJ; Tai J; Cheung SS; Ricordi C; Starzl TE
Transplant Proc; 1992 Dec; 24(6):2849-50. PubMed ID: 1281577
[No Abstract] [Full Text] [Related]
23. Effect of mycophenolate mofetil on islet allografting to chemically induced or spontaneously diabetic animals.
Hao L; Wang Y; Chan SM; Lafferty KJ
Transplant Proc; 1992 Dec; 24(6):2843-4. PubMed ID: 1465967
[No Abstract] [Full Text] [Related]
24. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
25. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
26. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.
Shehadeh NN; LaRosa F; Lafferty KJ
J Autoimmun; 1993 Jun; 6(3):291-300. PubMed ID: 8397713
[TBL] [Abstract][Full Text] [Related]
27. [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice].
Wang XX; Niu XH; Zhou ZG
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):105-7. PubMed ID: 12575330
[TBL] [Abstract][Full Text] [Related]
28. Destruction of transplanted beta cells into diabetic NOD mice is not mediated by antibody alone.
Hodgson RJ; Loudovaris T; Charlton B; Mandel TE
Transplant Proc; 1992 Oct; 24(5):2300. PubMed ID: 1413067
[No Abstract] [Full Text] [Related]
29. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
30. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.
Korbutt GS; Suarez-Pinzon WL; Power RF; Rajotte RV; Rabinovitch A
Diabetologia; 2000 Apr; 43(4):474-80. PubMed ID: 10819241
[TBL] [Abstract][Full Text] [Related]
31. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
33. Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression.
de Villa VH; Cienfuegos JA; Hernandez JL; Pardo F; Benito C; Balen E; Saez E; Alava E
Transplant Proc; 1992 Dec; 24(6):2984-5. PubMed ID: 1466024
[No Abstract] [Full Text] [Related]
34. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
35. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
[TBL] [Abstract][Full Text] [Related]
36. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
Henretta J; Pittman K; McFadden T; Thomas F
Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
[No Abstract] [Full Text] [Related]
37. Parameters of the immune status in patients with newly diagnosed type 1 diabetes mellitus after islet cell transplantation.
Dreval AV; Shishko PI; Skaletsky NN; Sadykova RE; Babicheva MG; Ignatenko NS; Efuni SS; Matukov AE; Polanskaya IS; Skuibin BG
Transplant Proc; 1992 Dec; 24(6):3041-2. PubMed ID: 1466048
[No Abstract] [Full Text] [Related]
38. Masking donor major histocompatibility complex class I antigens on allogeneic islets.
Munn SR; Marjoribanks C
Transplant Proc; 1992 Dec; 24(6):2857. PubMed ID: 1465973
[No Abstract] [Full Text] [Related]
39. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
[TBL] [Abstract][Full Text] [Related]
40. Prolongation of islet allograft survival is facilitated by storage conditions using cryopreservation involving fast cooling and/or tissue culture.
Taylor MJ; Foreman J; Biwata Y; Tsukikawa S
Transplant Proc; 1992 Dec; 24(6):2860-2. PubMed ID: 1465975
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
